Skip to main content

Peer Review reports

From: Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis

Original Submission
5 Dec 2019 Submitted Original manuscript
8 Feb 2020 Reviewed Reviewer Report - Andreas Kronbichler
20 Feb 2020 Reviewed Reviewer Report - Eduardo H. Garin
2 Mar 2020 Author responded Author comments - Panupong Hansrivijit
9 Mar 2020 Reviewed Reviewer Report - Andreas Kronbichler
18 Mar 2020 Reviewed Reviewer Report - Eduardo H. Garin
19 Mar 2020 Author responded Author comments - Panupong Hansrivijit
Resubmission - Version 2
2 Mar 2020 Submitted Manuscript version 2
20 Mar 2020 Reviewed Reviewer Report - Andreas Kronbichler
22 Mar 2020 Reviewed Reviewer Report - Eduardo H. Garin
2 Apr 2020 Author responded Author comments - Panupong Hansrivijit
Resubmission - Version 3
2 Apr 2020 Submitted Manuscript version 3
Publishing
6 Apr 2020 Editorially accepted
15 Apr 2020 Article published 10.1186/s12882-020-01797-7

You can find further information about peer review here.

Back to article page